- Home
- CRIS vs NXGL Comparison
CRIS vs NXGL Comparison
Compare CRIS & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- NXGL
- Stock Information
- Founded
- CRIS 2000
- NXGL 1997
- Country
- CRIS United States
- NXGL United States
- Employees
- CRIS N/A
- NXGL N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- NXGL Medical/Dental Instruments
- Sector
- CRIS Health Care
- NXGL Health Care
- Exchange
- CRIS Nasdaq
- NXGL Nasdaq
- Market Cap
- CRIS 22.9M
- NXGL 18.7M
- IPO Year
- CRIS 2000
- NXGL 2021
- Fundamental
- Price
- CRIS $1.61
- NXGL $2.60
- Analyst Decision
- CRIS Strong Buy
- NXGL
- Analyst Count
- CRIS 2
- NXGL 0
- Target Price
- CRIS $16.50
- NXGL N/A
- AVG Volume (30 Days)
- CRIS 72.1K
- NXGL 59.5K
- Earning Date
- CRIS 11-13-2025
- NXGL 11-12-2025
- Dividend Yield
- CRIS N/A
- NXGL N/A
- EPS Growth
- CRIS N/A
- NXGL N/A
- EPS
- CRIS N/A
- NXGL N/A
- Revenue
- CRIS $11,405,000.00
- NXGL $11,672,000.00
- Revenue This Year
- CRIS $2.72
- NXGL $46.60
- Revenue Next Year
- CRIS $8.27
- NXGL $47.96
- P/E Ratio
- CRIS N/A
- NXGL N/A
- Revenue Growth
- CRIS 12.24
- NXGL 133.02
- 52 Week Low
- CRIS $1.02
- NXGL $2.10
- 52 Week High
- CRIS $5.27
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- CRIS 50.58
- NXGL 53.56
- Support Level
- CRIS $1.49
- NXGL $2.58
- Resistance Level
- CRIS $1.63
- NXGL $2.85
- Average True Range (ATR)
- CRIS 0.10
- NXGL 0.17
- MACD
- CRIS 0.01
- NXGL 0.00
- Stochastic Oscillator
- CRIS 68.87
- NXGL 51.41
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.